About LIFE Worldwide

Your time is precious, so we summarise the take-home messages from the scientific literature and medical community that help you to improve your clinical practice.

  • When to suspect a fungal infection
  • Selecting and interpreting the right diagnostics
  • Promptly initiating the best evidence-based treatment(s)

Mission statement: to improve health outcomes for those with fungal infections or allergies by delivering free medical education (#MedEd) materials and the latest news to clinicians and medical lab staff around the world.

Target audience: doctors, nurses, radiologists, laboratory staff, ophthalmologists, critical care units, paediatricians, transplant centres, physiotherapists, epidemiologists, public health professionals, general practitioners, dermatologists, HIV/AIDS centres.

International outlook: each country faces a different set of challenges depending on endemic mycoses and prevalence of underlying factors (e.g. HIV/AIDS, TB). Each healthcare system is different, and may be limited by factors such as funding and which drugs are registered in that country. However, high-quality education in multiple languages can help everyone to make the best of what resources are available.

Location and funding: we are based within the National Aspergillosis Centre at Wythenshawe Hospital (part of Manchester University NHS Foundation Trust). We are supported by the Fungal Infection Trust, a UK charitable foundation set up 20 years ago.

Our team

  • Has cared for patients with fungal infections for 30 years
  • Founded the National Aspergillosis Centre (Manchester, UK), a specialist NHS care commissioning group that treats patients with CPA, ABPA and other forms of aspergillosis and provides information and support to patients and their doctors.
  • Founded the spinout company F2G Ltd, which is currently conducting a phase 2b clinical trial of olorofim (formerly F901318), an orotomide antifungal with a novel mechanism of action.
  • Founded Myconostica Ltd, which develops rapid  molecular diagnostics for invasive fungal infections.
  • Scientific Director of the Fungal Infection Trust, as UK charitable foundation (Charity Commission no. 1147658).
  • Chief Executive of the Global Action For Fungal Infections (GAFFI), an advocacy organisation that pushes for universal access to fungal diagnostics and treatments, for example by ensuring they are represented on the WHO Essential Diagnostics List and Essential Medicines List.
  • Active participant in drafting guidelines and the mycoses section of the ICD-11.
  • Read his publications

International advisers

Professor Juan Luis Rodríguez Tudela (@jlrtudela1)

Spanish language editor

  • Previously Director of the National Centre for Microbiology of Instituto de Salud Carlos III (2000-2003), where he founded the Medical Mycology Reference Laboratory of Spain
  • Served on several international associations, ex-Chairman of the Steering Committee of AFST-EUCAST and advisor of the PAHO on the Antifungal Resistance Surveillance Network in Latin-America.
  • Co-ran several workshops focused in diagnosis and resistance detection of fungi in different countries of American continent as Argentina, Brazil, Chile, Colombia, Cuba, and Mexico.
Scroll to top